Rivastigmine patch (Exelon patch) compared to melatonin patch in prevention of postoperative delirium in the elderly | ||||
| Ain-Shams Journal of Anesthesiology | ||||
| Volume 12, Issue 1, January 2020 PDF (559.88 K) | ||||
| DOI: 10.1186/s42077-020-00087-6 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Rania Maher Hussien   ; Aktham Adel Shoukry
| ||||
| Abstract | ||||
| Background Postoperative delirium (PD) is an acute, transient disorder of consciousness, attention, perception, and cognition. Many theories, such as decreased cholinergic neurotransmission and surgery-induced disturbances in melatonin secretion, were proposed as a potential cause for developing PD especially in the elderly. Methods In this double blinded randomized study, 180 elderly patients, ASA I–III, aged 60–85 years undergoing major orthopaedic surgery were divided into two equal groups; group R patients received a rivastigmine patch (4.6 mg) and group M patients received a melatonin patch (7 mg). Both patches were administered 24 h preoperative, on the day of operation and for the following 3 postoperative days. All patients received regional anaesthesia and basic monitoring in the form of NIBP, SPO, and ECG. Patients were examined for PD using the Confusion Assessment Method (CAM) and level of sedation using the Ramsay Sedation Score (RSS) on the first, second, third, and 7th postoperative day, and for those who develop PD, a CAM-S score was done to assess the severity of PD. Drug-related side effects were recorded. Statistical analyses were performed using a standard SPSS software. Results CAM score was positive in a total of 39 patients. Rivastigmine patch significantly decreased the incidence of PD when compared to melatonin patch ( value 0.047). However, CAM-S indicated that the severity of PD was comparable. Patients were more sedated in the melatonin group. There were no melatonin- nor rivastigmine-related perioperative complications. Intraoperative SBP, DBP, and HR were slightly less in melatonin group, although statistically non-significant. Conclusions Rivastigmine patch is superior to melatonin patch in decreasing the incidence of PD in elderly patients undergoing major orthopaedic surgery; however, both drugs were comparable in decreasing its severity. Trial registration Clinical , . December 6, 2019, prospectively registered | ||||
| Keywords | ||||
| Rivastigmine patch; Melatonin patch; postoperative delirium; CAM-S; CAM | ||||
|
Statistics Article View: 14 PDF Download: 16 |
||||
